PORTO-
FREI

Renal Pharmacotherapy

Dosage Adjustment of Medications Eliminated by the Kidneys

von Golightly, Larry K. / Teitelbaum, Isaac / Stolpman, Nancy M. / Kiser, Tyree H. / Barber, Gerard R. / Simendinger, Bonita A.   (Autor)

To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications.This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types.Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.

Buch (Kartoniert)

EUR 74,89

Alle Preisangaben inkl. MwSt.

Auch verfügbar als:

  Verlagsbedingte Lieferzeit ca. 3 - 6 Werktage.
(Print on Demand. Lieferbar innerhalb von 3 bis 6 Tagen)

Versandkostenfrei*

Dieser Artikel kann nicht bestellt werden.
 

Produktbeschreibung

To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications.This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all typesprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function. 

Inhaltsverzeichnis


A: Acamprosate to Aztreonam

B: Bacitracin to Butorphanol

C: Capecitabine to Cycloserine

D: Dabigatran to Dyphylline

E: Edetate Calcium Disodium to Exenatide

F: Famciclovir to Fosfomycin

G: Gabapentin to Glyburide

H: Hetastarch to Hydroxyurea

I: Ibandronate to Itraconazole

K: Kanamycin to Ketorolac

L: Lacosamide to Lurasidone

M: Magnesium Citrate to Mycophenolate Mofetil

N: Nabumetone to Norfloxacin

O: Ofloxacin to Oxcarbazepine

P: Paliperidone to Pyridostigmine

Q: Quinapril to Quinine

R: Ramipril to Ruxolitinib

S: Salsalate to Sunitinib

T: Tadalafil to Trospium

V: Valacyclovir to Voriconazole

Z: Zalcitabine to Zonisamide

Proprietary Name Index 

Autoreninfo


Larry K. Golightly, PharmD

Clinical Research Pharmacist

University of Colorado Hospital
Aurora, CO 80045 

Produktdetails

Medium: Buch
Format: Kartoniert
Seiten: 856
Sprache: Englisch
Erschienen: September 2021
Auflage: 2nd ed. 2021
Band-Nr.: 1. Halbband
Sonstiges: 978-3-030-58649-2
Maße: 279 x 210 mm
Gewicht: 2292 g
ISBN-10: 3030586499
ISBN-13: 9783030586492

Bestell-Nr.: 29781800 
Libri-Verkaufsrang (LVR):
Libri-Relevanz: 0 (max 9.999)
 

Ist ein Paket? 1
Rohertrag: 17,50 €
Porto: 4,06 €
Deckungsbeitrag: 13,44 €

LIBRI: 0000000
LIBRI-EK*: 52.49 € (25.00%)
LIBRI-VK: 74,89 €
Libri-STOCK: 0
LIBRI: 097 Print on Demand. Lieferbar innerhalb von 7 bis 10 Tagen * EK = ohne MwSt.

UVP: 2 
Warengruppe: 26960 

KNO: 86016065
KNO-EK*: 114.64 € (25.00%)
KNO-VK: 181,89 €
KNV-STOCK: 0

KNOABBVERMERK: 2. Aufl. 2021. xxvi, 827 S. XXVI, 827 p. 2 illus. 279 mm
KNOSONSTTEXT: 978-3-030-58649-2
KNOZUSATZTEXT: Bisherige Ausg. siehe T.-Nr.34443207.
KNO-BandNr. Text:1. Halbband
Einband: Kartoniert
Auflage: 2nd ed. 2021
Sprache: Englisch
Beilage(n): Paperback

Alle Preise inkl. MwSt. , innerhalb Deutschlands liefern wir immer versandkostenfrei . Informationen zum Versand ins Ausland .

Kostenloser Versand *

innerhalb eines Werktages

OHNE RISIKO

30 Tage Rückgaberecht

Käuferschutz

mit Geld-Zurück-Garantie